Both estimate biological age. Neither is lying to you. But each has a specific, documented limitation the other does not share — and most comparisons online skip both of them.
| Epigenetic clock | biomarker calculator | |
|---|---|---|
| What it measures | Chemical marks on DNA (methylation), from blood or saliva | Blood pressure, lipids, glucose, inflammation — direct physiological readings |
| Typical cost | $249–$499 per test (e.g., TruDiagnostic's TruAge/TruHealth kits) | Free, from blood work you may already have |
| Turnaround | 3–6 weeks (lab processing and report) | Minutes, once you have your numbers |
| Tells you which system is off | The peer-reviewed clocks (Horvath, PhenoAge, GrimAge) return one number; newer proprietary organ-level products exist but are not yet independently peer-reviewed | Yes — eight systems scored and reported separately, formula published |
| Same sample, tested twice | Standard clocks can disagree by several years on technical noise alone | Deterministic — identical inputs always produce an identical score |
| Best validated for | Predicting population-level mortality and disease risk | Tracking your own change against published thresholds over time |
Epigenetic clocks read DNA methylation — chemical marks that accumulate on DNA in patterned ways with age — from a blood or saliva sample. Horvath's 2013 clock was the first widely used version; Hannum, PhenoAge, GrimAge and DunedinPACE followed, each trained on different outcomes and each capable of producing a different number from the same sample. This calculator is a different kind of instrument entirely: it scores real physiological measurements — blood pressure, lipid particles, fasting insulin, grip strength and more — against published longevity-optimised thresholds. Neither approach is more "real" than the other; they are measuring different layers of biology and were validated against different outcomes.
The peer-reviewed clocks that get cited in research — Horvath, Hannum, PhenoAge, GrimAge, DunedinPACE — each return a single age or pace estimate. A result of "you are biologically 52 against a chronological age of 45" tells you acceleration exists. It does not tell you whether that acceleration is coming from your cardiovascular system, your metabolism, your kidneys or somewhere else, because the model was never built to decompose into systems — it was built to predict mortality as accurately as possible from methylation data as a whole.
Newer commercial products are starting to close this gap — TruDiagnostic's SYMPHONYAge, for instance, attempts to estimate ages for 11 individual organ systems from the same kind of methylation data. It is a genuinely interesting development, and it exists precisely because the single-number limitation is real and recognised in the field. As of this writing it is described in a preprint rather than a peer-reviewed publication, and the underlying model weights are proprietary to the company rather than published the way PhenoAge's or GrimAge's formulas are — so it cannot yet be independently checked the way the older clocks, or this tool's own thresholds, can.
This is the specific gap eight separately-scored dials are built to close: not a claim that methylation is the wrong signal, but a structural one. A composite that reports one number, however it was derived, cannot show you that your vascular dial is fine while your inflammatory dial is not — the averaging itself destroys that information. See why one number is not enough for the fuller version of this argument.
A 2022 study in Nature Aging (Higgins-Chen et al.) tested several widely-used epigenetic clocks by measuring the same blood sample twice and comparing the two results. For the standard clocks, technical noise alone — not any real biological change — could shift the reported epigenetic age by as much as nine years between the two readings of the identical sample. The same paper proposed a fix (principal-component, or "PC", clocks) that brought repeat-measurement disagreement down to under a year for most tests — a real and important improvement, but one that depends on which specific clock, and which specific lab's implementation of it, you are actually being sold.
This matters most for the exact use case this tool is built around: retesting to see if something you changed actually worked. If an instrument's own measurement noise can rival or exceed the biological change you are trying to detect, a lower number after three months of training could be real progress, or could be nothing more than two readings of the same underlying biology landing on different sides of the noise — and there is no way to tell which from the number alone, unless you specifically know which clock variant you used and whether it was built to be retest-stable. A biomarker panel built from deterministic, published arithmetic does not have this problem by construction: the same inputs produce the same output on the first run and the hundredth, which is also why this tool treats a conversational AI model the same way it treats an unvalidated clock — see why a fixed method matters for tracking for that half of the same argument.
None of this makes DNA methylation the wrong tool for what it is good at. GrimAge and DunedinPACE in particular are validated against real mortality and disease outcomes in large longitudinal cohorts, at a level of research rigor few biomarker-panel methods can claim individually. DunedinPACE specifically estimates your current pace of aging rather than a static level, which is a genuinely different and useful question a biomarker snapshot does not directly answer.
If the question is "how fast am I aging, in a way that would hold up to a researcher's scrutiny", a clock — specifically one of the newer, retest-stable variants — is the better-validated instrument for that exact question.
A clock answers a research-grade question about aging rate and mortality risk, at a cost and turnaround that make repeating it every few months impractical for most people. A biomarker panel answers a narrower, more immediately actionable question — which system is driving your risk right now, and did your last three months of training or treatment move it — at a cost and turnaround that make retesting routine rather than a special occasion.
If you can afford both, a clock once every year or two for the mortality-risk signal, alongside a biomarker panel every 8–12 weeks for what to actually do next, covers more ground than either alone.
Yes, and they complement each other well. A clock gives you a population-validated mortality-risk signal; this tool gives you a system-level breakdown and a deterministic way to track whether a specific change worked. Neither replaces the other.
They are measuring different layers of biology, trained against different outcomes, and in the case of standard clocks, carrying real measurement noise of their own. Disagreement between the two is expected and does not mean either number is wrong — it means they answer different questions.
Not necessarily, and not in the way that matters for tracking your own change. Cost reflects lab processing and proprietary algorithms, not test-retest reliability specifically — a published 2022 study found standard DNA methylation clocks could disagree by up to nine years on repeat measurement of the identical sample, regardless of price.
See where you sit →Related: epigenetic age vs biological age · what is biological age · chatgpt lab results · methodology
Choose a question. Answers come from this site, and nothing you open is sent anywhere.
Yes, and they complement each other well. A clock gives you a population-validated mortality-risk signal; this tool gives you a system-level breakdown and a deterministic way to track whether a specific change worked. Neither replaces the other.
They are measuring different layers of biology, trained against different outcomes, and in the case of standard clocks, carrying real measurement noise of their own. Disagreement between the two is expected and does not mean either number is wrong — it means they answer different questions.
Not necessarily, and not in the way that matters for tracking your own change. Cost reflects lab processing and proprietary algorithms, not test-retest reliability specifically — a published 2022 study found standard DNA methylation clocks could disagree by up to nine years on repeat measurement of the identical sample, regardless of price.
Chronological age counts birthdays. Biological age estimates how old your body appears to be functioning, based on measurable biomarkers. Two people born the same year can differ by a decade or more in vascular stiffness, insulin signalling or cardiorespiratory fitness. Biological age makes that gap explicit — and unlike your birthday, it can move in either direction.
Each biomarker you enter is scored against longevity-optimised reference ranges and grouped into one of eight dials. Every dial produces its own biological age, and those are combined using fixed weights into a single composite, then expressed as a Longevity Score from 0 to 100. The weighting reflects how strongly each system predicts healthspan: structural and vascular carry the most, hormonal the least.
No. The short form contains a subset of scoring inputs plus context-only fields, and you can leave any of them blank. It is not a recommendation to obtain tests. Missing values are excluded from the calculation — never treated as zero or as 'normal'. A dial with no scored data is dropped entirely and the remaining weights renormalise.
Some inputs can be measured without bloodwork. Blood pressure needs a home cuff and waist-to-height needs a tape measure. Wearable estimates vary; the floor-based sitting-rising test carries a fall risk and should only be attempted if safe.
Both terms describe what this tool does, and which one fits depends on what you are asking. "Anti-aging" is the term most people search, and loosely means anything aimed at slowing or reversing age-related decline — this tool fits that description if you score your dials and act on what you find. "Healthspan calculator" is the more precise term: healthspan is the number of years lived without serious chronic disease or disability, and that cannot be measured directly, so this tool scores eight systems that each function as an early-warning proxy for it. Either way, the method is the same: real biomarkers, published thresholds, no vanity-metric framing.
Several popular tools ask only about habits — exercise days, sleep hours, smoking, diet quality — and return a single precise-looking age. We looked at the research behind that approach and chose not to build it. Published studies do show real, individually-measured links between specific habits and epigenetic age acceleration, but those effect sizes come from different study populations, different DNA-methylation clocks and different measurement units. Adding them together into one number is not something the underlying research actually supports — it produces a precise-looking result built on an imprecise method. Our dials use direct physiological measurements instead: a real blood pressure reading, a real VO₂ max, a real ApoB value. Several dials score from home-measurable data alone with no quiz-guessing involved — see what you can measure without a blood test, above.
Standard reference ranges describe what is common in a general population, which now includes a great deal of metabolic dysfunction. They are tuned to flag disease, not to identify what is optimal for a long healthspan. A fasting insulin of 20 µIU/mL sits inside most labs' normal range and is strongly associated with insulin resistance. This tool uses longevity-optimised thresholds instead, so a flag here means room for optimisation — not a diagnosis.